Clinical Trial Update: Comparison of Aripiprazole Versus Higher Metabolic Risk Antipsychotic Drugs on Adiposity Using MRI

View source ↗

Summary

This completed trial compared aripiprazole with higher metabolic-risk antipsychotics to evaluate adiposity changes via MRI in individuals with psychotic disorde…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Metabolic Syndrome
• Psychotic Disorders

Drugs mentioned

• Abilify (aripiprazole)

Snippet

Sponsor: University of British Columbia | Conditions: Psychotic Disorders, Bipolar Disorder | Status: COMPLETED